Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
43.51
-0.54 (-1.23%)
Nov 21, 2024, 4:00 PM EST - Market closed
Kymera Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$52.14
Upside
+19.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Initiates $65 | Buy | Initiates | $65 | +49.39% | Nov 18, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $45 → $49 | Hold | Maintains | $45 → $49 | +12.62% | Nov 6, 2024 |
| UBS | UBS | Strong Buy Maintains $80 → $74 | Strong Buy | Maintains | $80 → $74 | +70.08% | Nov 4, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $54 → $53 | Strong Buy | Reiterates | $54 → $53 | +21.81% | Nov 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $52 → $56 | Buy | Maintains | $52 → $56 | +28.71% | Sep 27, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $60 | Buy | Initiates | $60 | +37.90% | Sep 9, 2024 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $65 | Hold → Buy | Upgrades | $65 | +49.39% | Aug 26, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $34 → $45 | Hold | Maintains | $34 → $45 | +3.42% | Aug 14, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $30 → $38 | Hold | Maintains | $30 → $38 | -12.66% | Aug 12, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $52 | Buy | Maintains | $52 | +19.51% | Jul 10, 2024 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $31 → $36 | Hold | Maintains | $31 → $36 | -17.26% | Jul 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $46 | Strong Buy | Reiterates | $46 | +5.72% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $46 | Strong Buy | Reiterates | $46 | +5.72% | Jun 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $46 → $30 | Strong Buy | Reiterates | $46 → $30 | -31.05% | May 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $53 → $52 | Buy | Maintains | $53 → $52 | +19.51% | May 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $53 | Buy | Initiates | $53 | +21.81% | Apr 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.